The US Food and Drug Administration (FDA) has approved the use of Aziyo Biologics’ bioscaffold CanGaroo Envelope with implantable neurostimulator devices.

CanGaroo is an extracellular matrix (ECM) envelope that is developed to securely hold cardiac implantable electronic devices (CIED) after implantation.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It uses a multi-laminate sheet of decellularised, non-crosslinked, lyophilised ECM procured from porcine small intestinal submucosa (SIS). It becomes a vascularised pocket over time to expedite future removal or alterations.

“Products such as the CanGaroo Envelope have become invaluable to electrophysiologists in helping reduce some of the complications associated with implantable devices.”

The device was previously received 510(k) FDA clearance for use with pacemakers, defibrillators and other CIEDs. This latest clearance expands its use to spinal cord neuromodulators and vagus nerve, deep brain and sacral nerve stimulators.

Aziyo Biologics’ president and CEO Ron Lloyd said: “CanGaroo has been used by electrophysiologists since 2014 to improve patient outcomes in CIED procedures and we’re excited to now expand this offering to neurosurgeons as well.

“We are committed to driving the tremendous potential of our regenerative medicine products to make positive advances for patients and the professionals and organisations that serve them.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The University of Florida’s electrophysiologist John N. Catanzaro said: “Products such as the CanGaroo Envelope have become invaluable to electrophysiologists in helping reduce some of the complications associated with implantable devices while maintaining a more natural type of healing process.

“Expanding use to the field of neurostimulation will greatly benefit both subsets of patients who require these devices.”